Title : Erlotinib resistance is altered after gemcitabine chemotherapy for recurrent non-small-cell lung cancer.

Pub. Date : 2011

PMID : 21080748






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We report the case of a male Mongolian lifelong non-smoker with recurrent non-small-cell lung cancer (NSCLC) who developed resistance to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib after initially responding to this agent but then subsequently had another response to a second course of erlotinib treatment after intervening gemcitabine chemotherapy. gemcitabine epidermal growth factor receptor Homo sapiens
2 We report the case of a male Mongolian lifelong non-smoker with recurrent non-small-cell lung cancer (NSCLC) who developed resistance to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib after initially responding to this agent but then subsequently had another response to a second course of erlotinib treatment after intervening gemcitabine chemotherapy. gemcitabine epidermal growth factor receptor Homo sapiens